GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jerusalem Pharmaceutical Co (XPAE:JPH) » Definitions » Cyclically Adjusted FCF per Share

Jerusalem Pharmaceutical Co (XPAE:JPH) Cyclically Adjusted FCF per Share : $0.34 (As of Dec. 2024)


View and export this data going back to 1997. Start your Free Trial

What is Jerusalem Pharmaceutical Co Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Jerusalem Pharmaceutical Co's adjusted free cash flow per share for the three months ended in Dec. 2024 was $0.172. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is $0.34 for the trailing ten years ended in Dec. 2024.

During the past 12 months, Jerusalem Pharmaceutical Co's average Cyclically Adjusted FCF Growth Rate was 21.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2025-05-23), Jerusalem Pharmaceutical Co's current stock price is $3.85. Jerusalem Pharmaceutical Co's Cyclically Adjusted FCF per Share for the quarter that ended in Dec. 2024 was $0.34. Jerusalem Pharmaceutical Co's Cyclically Adjusted Price-to-FCF of today is 11.32.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Jerusalem Pharmaceutical Co was 16.52. The lowest was 10.85. And the median was 12.73.


Jerusalem Pharmaceutical Co Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Jerusalem Pharmaceutical Co's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jerusalem Pharmaceutical Co Cyclically Adjusted FCF per Share Chart

Jerusalem Pharmaceutical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 0.25 0.28 0.34

Jerusalem Pharmaceutical Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.28 0.29 0.32 0.33 0.34

Competitive Comparison of Jerusalem Pharmaceutical Co's Cyclically Adjusted FCF per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Jerusalem Pharmaceutical Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jerusalem Pharmaceutical Co's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Jerusalem Pharmaceutical Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Jerusalem Pharmaceutical Co's Cyclically Adjusted Price-to-FCF falls into.


;
;

Jerusalem Pharmaceutical Co Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Jerusalem Pharmaceutical Co's adjusted Free Cash Flow per Share data for the three months ended in Dec. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=0.172/133.1571*133.1571
=0.172

Current CPI (Dec. 2024) = 133.1571.

Jerusalem Pharmaceutical Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201503 -0.111 99.621 -0.148
201506 -0.058 100.684 -0.077
201509 0.120 100.392 0.159
201512 0.059 99.792 0.079
201603 -0.047 100.470 -0.062
201606 0.005 101.688 0.007
201609 0.013 101.861 0.017
201612 0.122 101.863 0.159
201703 -0.093 102.862 -0.120
201706 0.075 103.349 0.097
201709 0.009 104.136 0.012
201712 0.267 104.011 0.342
201803 -0.049 105.290 -0.062
201806 0.083 106.317 0.104
201809 0.184 106.507 0.230
201812 0.023 105.998 0.029
201903 -0.035 107.251 -0.043
201906 0.041 108.070 0.051
201909 0.005 108.329 0.006
201912 -0.025 108.420 -0.031
202003 0.028 108.902 0.034
202006 0.060 108.767 0.073
202009 -0.071 109.815 -0.086
202012 0.033 109.897 0.040
202103 0.256 111.754 0.305
202106 -0.002 114.631 -0.002
202109 0.125 115.734 0.144
202112 -0.042 117.630 -0.048
202203 0.266 121.301 0.292
202206 0.332 125.017 0.354
202209 0.122 125.227 0.130
202212 0.204 125.222 0.217
202303 0.260 127.348 0.272
202306 0.255 128.729 0.264
202309 0.253 129.860 0.259
202312 -0.255 129.419 -0.262
202403 0.061 131.776 0.062
202406 0.317 132.554 0.318
202409 0.103 133.029 0.103
202412 0.172 133.157 0.172

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Jerusalem Pharmaceutical Co  (XPAE:JPH) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Jerusalem Pharmaceutical Co's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=3.85/0.34
=11.32

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Jerusalem Pharmaceutical Co was 16.52. The lowest was 10.85. And the median was 12.73.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Jerusalem Pharmaceutical Co Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Jerusalem Pharmaceutical Co's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Jerusalem Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
Nablus Street, Jerusalem Pharmaceuticals Company Buliding, Al Bireh Industrial Zone, Al Bireh, PSE, 3570
Jerusalem Pharmaceutical Co is engaged in developing, manufacturing and marketing of human pharmaceuticals products. It also produces detergent, cosmetic, personal and home care products, veterinary and agricultural products. The company operates in Jordan, Algeria, the Middle East, and North Africa Region. Its product portfolio contains more than 300 pharmaceutical products in various dosage forms including tablets, capsules, sterile injectables, powders for suspensions, suspensions, syrups, powders, suppositories, ovules, creams, ointments, as well as ear and nose drops and solutions.

Jerusalem Pharmaceutical Co Headlines

No Headlines